We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -38.00 | -0.32% | 11,988.00 | 12,014.00 | 12,018.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 12,144.00 | 11,882.00 | 12,070.00 | 2,340,814 | 16:35:09 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.28 | 186.27B |
| Date | Time | Source | Headline |
|---|---|---|---|
| 25/4/2024 | 09:18 | ALNC |  TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth |
| 25/4/2024 | 07:00 | UK RNS | AstraZeneca PLC 1st Quarter Results |
| 24/4/2024 | 10:32 | ALNC | Angle shares jump on supplier agreement with with AstraZeneca |
| 16/4/2024 | 11:38 | ALNC | IN THE KNOW: Deutsche ups AstraZeneca as higher payout addresses worry |
| 16/4/2024 | 08:39 | ALNC | AstraZeneca's hails Imfinzi survival data on cancer form |
| 11/4/2024 | 17:42 | ALNC | *AstraZeneca AGM resolutions pass, but 36% vote against remuneration policy |
| 11/4/2024 | 17:30 | UK RNS | AstraZeneca PLC Result of AGM |
| 11/4/2024 | 08:56 | ALNC | TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023 |
| 11/4/2024 | 07:00 | UK RNS | AstraZeneca PLC AstraZeneca increases 2024 dividend by 7% |
| 08/4/2024 | 08:36 | ALNC | TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris |
1 Year Astrazeneca Chart |
Intraday Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
